PSTI insider filings
PLURISTEM THERAPEUTICS INC — 22 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-02-14. Screen PSTI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PSTI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — PLURISTEM THERAPEUTICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-02-14 | 4 | Aberman Zami — Director | Purchase (P): 80,616 @ $1.80 | EDGAR |
| 2021-07-26 | 4 | Shalev Varda — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2021-07-26 | 4 | Birger Pinhas Doron — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2021-06-01 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Sale (S): 122,663 @ $3.68 · Sale (S): 22,015 @ $3.69 · Sale (S): 71,775 @ $3.69 · Sale (S): 24,110 @ $3.69 · Sale (S): 70,007 @ $3.72 · Sale (S): 45,000 @ $3.72 | EDGAR |
| 2021-05-27 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Sale (S): 69,838 @ $3.98 · Sale (S): 79,300 @ $3.83 · Sale (S): 261,238 @ $3.84 | EDGAR |
| 2021-05-04 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Sale (S): 166,004 @ $4.66 · Sale (S): 23,721 @ $4.28 | EDGAR |
| 2021-01-07 | 4 | Levi Rami Avraham — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2021-01-06 | 4 | Shemesh-Rasmussen Maital — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-12-01 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 20,000 @ $9.70 | EDGAR |
| 2020-11-03 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 25,000 @ $9.60 · Purchase (P): 25,000 @ $9.42 | EDGAR |
| 2020-10-29 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 20,000 @ $9.20 | EDGAR |
| 2020-10-01 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 60,123 @ $9.76 · Purchase (P): 139,006 @ $10.34 | EDGAR |
| 2020-09-29 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 13,189 @ $9.49 | EDGAR |
| 2020-09-25 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 34,800 @ $9.02 | EDGAR |
| 2020-09-24 | 4 | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP — 10% owner | Purchase (P): 8,458 @ $9.05 · Purchase (P): 2,276 @ $8.98 | EDGAR |
| 2020-09-10 | 4 | Kwiat Moria — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | GERMAIN MARK — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | SHORRER DORON — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | BRAUN ISAAC — Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | Franco-Yehuda Chen — Chief Financial Officer | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | YANAY YAKY — CEO & President, Director | Grant/award (A): 500,000 @ $0 · Grant/award (A): 500,000 @ $0 | EDGAR |
| 2020-09-10 | 4 | Aberman Zami — Executive Chairman, Director | Grant/award (A): 500,000 @ $0 · Grant/award (A): 500,000 @ $0 | EDGAR |
Recent 8-K events — PLURISTEM THERAPEUTICS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-06-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events | EDGAR |
Registration filings — PLURISTEM THERAPEUTICS INC
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-299324 (S-1) — latest: Initial registration (S-1), filed 2026-10-06
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PSTI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs